Growth hormone (GH) replacement in hypopituitary adults with GH deficiency evaluated by a utility-weighted quality of life index: A precursor to cost-utility analysis

Clinical Endocrinology

Volumn 68, Issue 1, 2008, Pages 122-129

  Kołtowska Häggström, Maria ^a,b   Kind, Paul ^c   Monson, John P ^d   Jonsson, Björn ^b  

^a PFIZER INC   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF YORK   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADULT; ARTICLE; CONTROLLED STUDY; COST OF ILLNESS; DATA ANALYSIS; DEMOGRAPHY; FEMALE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE INDEX; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; DWARFISM, PITUITARY; FEMALE; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOPITUITARISM; MALE; MIDDLE AGED; QUALITY OF LIFE; YOUNG ADULT;

EID: 37449004445     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03010.x     Document Type: Article

References (32)

1. Torrance, G.W. (1986) Measurement of health state utilities for economic appraisal. Journal of Health Economics, 5, 1 30.
2. Fayers, P.M. Machin, D. (2000) Introduction. In : Quality of Life, Assessment, Analysis and Interpretation. Wiley, Chichester, 3 27.
3. Carroll, P.V., Christ, E.R., Bengtsson, B.-Å., Carlsson, L., Christiansen, J.S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., Sönksen, P.H., Tanaka, T. Thorne, M. (1998) Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. Journal of Clinical Endocrinology and Metabolism, 83, 382 395.
4. Radcliffe, D.J., Pliskin, J.S., Silvers, J.B. Cuttler, L. (2004) Growth hormone therapy and quality of life in adults and children. Pharmacoeconomics, 22, 499 524.
5. McKenna, S.P., Doward, L.C., Alonso, J., Kohlmann, T., Niero, M., Prieto, L. Wiren, L. (1999) The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Quality of Life Research, 8, 373 383.
6. Herschbach, P., Henrich, G., Strasburger, C.J., Feldmeier, H., Marin, F., Attanasio, A.M. Blum, W.F. (2001) Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency. European Journal of Endocrinology, 145, 255 265.
7. Dixon, S., McEwan, P. Currie, C.J. (2003) Estimating the health utility of treatment in adults with growth hormone deficiency. Journal of Outcomes Research, 7, 1 12.
8. Koltowska-Häggström, M., Jonsson, B., Isacson, D. Bingefors, K. (2007) Using EQ-5D to derive general population-based utilities for the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA). Value in Health, 10, 73 81.
9. Marra, C.A., Woolcott, J.C., Kopec, J.A., Shojania, K., Offer, R., Brazier, J.E., Esdaile, J.M. Anis, A.H. (2005) A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Science and Medicine, 60, 1571 1582.
10. Krabbe, P.F., Peerenboom, L., Langenhoff, B.S. Ruers, T.J. (2004) Responsiveness of the generic EQ-5D summary measure compared to the disease-specific EORTC QLQ C-30. Quality of Life Research, 13, 1247 1253.
11. Buxton, M.J., Lacey, L.A., Feagan, B.G., Niecko, T., Miller, D.W. Townsend, R.J. (2007) Mapping from disease specific measures to utility: an analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's disease and measures of utility. Value in Health, 10, 214 220.
12. The EuroQol Group (1990) EuroQol - a new facility for the measurement of health-related quality of life. Health Policy, 16, 199 208.
13. Dolan, P. (1997) Modeling valuations for EuroQol health states. Medical Care, 35, 1095 1108.
14. Koltowska-Haggstrom, M., Hennessy, S., Mattsson, A.F., Monson, J.P. Kind, P. (2005) Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiency. Hormone Research, 64, 46 54.
15. Monson, J.P. (2003) KIMS: treating adult GH deficiency. Endocrinologist, 68, 10.
16. Dupuy, H.J. (1984) The Psychological General Well-Being (PGWB) index. In : N.K. Wenger, M.E. Mattson, C.F. Furberg, J. Elinson eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. Le Jacq, New York, 170 183.
17. KIMS Classification List (2004 R. Abs, U. Feldt-Rasmussen eds. Growth Hormone Deficiency in Adults: 10 Years of KIMS. Oxford PharmaGenesis, Oxford, 346 348.
18. Robinson, A., Dolan, P. Williams, A. (1997) Valuing health status using VAS and TTO: what lies behind the numbers? Social Science and Medicine, 45, 1289 1297.
19. van Osch, S.M.C., Wakker, P.P., van den Hout, W.B. Stiggelbout, A.M. (1999) Correcting biases in standard gamble and time tradeoff utilities. Medical Decision Making, 24, 511 517.
20. Dolan, P. (1999) Whose preferences count? Medical Decision Making, 19, 482 486.
21. Busschbach, J., Weijen, T., Nieuwenhuizen, M., Oppe, S., Badia, X., Dolan, P., Greiner, W., Kind, P., Krabbe, P., Ohinmaa, A., Roset, M., Sintonen, H., Tsuchiya, A., Williams, A., Yfantopoulos, J. De Charro, F. (2003) A comparison of EQ-5D time trade-off values obtained in Germany, The United Kingdom and Spain. In : R. Brooks ed. The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective. Kluwer Academic, Dordrecht, 143 165.
22. Bryant, J., Loveman, E., Chase, D., Mihaylova, B., Cave, C., Gerard, K. Milne, R. (2002) Clinical effectiveness and cost-effectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluation. Health Technology Assessment, 6, 1 106.
23. Koitowska-Häggström, M., Mattsson, A.F., Monson, J.P., Kind, P., Badia, X., Casanueva, F.F., Busschbach, J., Koppeschaar, H.P.F. Johannsson, G. (2006) Does long-term growth hormone replacement therapy in hypopituitary adults with growth-hormone deficiency normalise quality of life? European Journal of Endocrinology, 155, 109 119.
24. Saller, B., Mattsson, A.F., Kann, P.H., Koppeschaar, H.P., Svensson, J., Pompen, M. Koltowska-Häggström, M. (2006) Healthcare utilization, quality of life and patient-reported outcomes during two years of growth hormone (GH) replacement therapy in GH-deficient adults - comparison between Sweden, The Netherlands and Germany. European Journal of Endocrinology, 154, 843 850.
25. Rosilio, M., Blum, W.F., Edwards, D.J., Berthezene, F., Shavrikova, E.P., Valle, D., Lamberts, S.W.J., Erfurth, E.M., Webb, S.M., Ross, R.J., Chihara, K., Henrich, G., Herschbach, P. Attanasio, A.F. (2004) Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by Questions on Life Satisfaction-Hypopituitarism (QLS-H). Journal of Clinical Endocrinology and Metabolism, 89, 1684 1693.
26. Johannsson, G., Rosen, T. Bengtsson, B.-A. (1997) Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clinical Endocrinology, 47, 571 581.
27. Gold, M.R., Franks, P., McCoy, K.I. Fryback, D.G. (1998) Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Medical Care, 36, 778 792.
28. Burstrom, K., Johannesson, M. Diderichsen, F. (2001) Health-related quality of life by disease and socio-economic group in the general population in Sweden. Health Policy, 55, 51 69.
29. Monson, J.P. Jönsson, P. (2003) Aspects of growth hormone (GH) replacement in elderly patients with GH deficiency: data from KIMS. Hormone Research, 55 (Suppl. 1 112 120.
30. Burman, P. Deijen, J.B. (1998) Quality of life and cognitive function in patients with pituitary insufficiency. Psychotherapy and Psychosomatics, 67, 154 167.
31. Bates, A.S., Van't Hoff, W., Jones, P.J. Clayton, R.N. (1996) The effect of hypopituitarism on life expectancy. Journal of Clinical Endocrinology and Metabolism, 81, 1169 1172.
32. Rosén, T. Bengtsson, B.-Å. (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet, 336, 285 288.